Australia markets close in 1 hour 2 minutes

TheraVet SA (ALVET.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
0.6960-0.0040 (-0.57%)
At close: 05:35PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 2.24M
Enterprise value 2.26M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.08
Price/book (mrq)0.37
Enterprise value/revenue 2.09
Enterprise value/EBITDA -4.30

Trading information

Stock price history

Beta (5Y monthly) -0.26
52-week change 3-69.47%
S&P500 52-week change 323.57%
52-week high 32.4000
52-week low 30.6660
50-day moving average 30.9328
200-day moving average 31.2466

Share statistics

Avg vol (3-month) 39.31k
Avg vol (10-day) 36.5k
Shares outstanding 53.22M
Implied shares outstanding 63.29M
Float 8N/A
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -145.70%
Operating margin (ttm)-182.93%

Management effectiveness

Return on assets (ttm)-15.96%
Return on equity (ttm)-23.15%

Income statement

Revenue (ttm)1.08M
Revenue per share (ttm)0.33
Quarterly revenue growth (yoy)-32.10%
Gross profit (ttm)N/A
EBITDA -1.11M
Net income avi to common (ttm)-1.57M
Diluted EPS (ttm)-0.5000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.15M
Total cash per share (mrq)0.36
Total debt (mrq)1.16M
Total debt/equity (mrq)19.17%
Current ratio (mrq)3.40
Book value per share (mrq)1.88

Cash flow statement

Operating cash flow (ttm)-1.22M
Levered free cash flow (ttm)-1.05M